These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3128230)

  • 1. [Myocardial ischemia: definition and objectives of anti-ischemia therapy].
    Jaillon P
    Arch Mal Coeur Vaiss; 1987 Dec; 80 Spec No():11-3. PubMed ID: 3128230
    [No Abstract]   [Full Text] [Related]  

  • 2. [The ischemic heart--causes, effects and therapy].
    Tillmanns H
    Klin Anasthesiol Intensivther; 1995; 47():206-20. PubMed ID: 7715175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of cardiovascular diseases and sports].
    Rost R
    Internist (Berl); 1992 Mar; 33(3):136-41. PubMed ID: 1349878
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heart failure in coronary heart disease].
    Hauf GF; Roskamm H
    Internist (Berl); 1993 Oct; 34(10):953-60. PubMed ID: 8225845
    [No Abstract]   [Full Text] [Related]  

  • 5. [Problems in long-term therapy of coronary heart disease: clinical aspects].
    Stauch M; Schmidt A; Kress P
    Med Klin (Munich); 1987 Jan; 1():24-8. PubMed ID: 3106751
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current problems posed by myocardial ischemia].
    Duchêne-Marullaz P; Gourgon R; Luccioni R; Lekieffre J; Jourde M
    Sem Hop; 1981 Oct 18-25; 57(39-40):1618-9. PubMed ID: 6119790
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asymptomatic ischemia--an important part of the spectrum of coronary disease].
    Rutishauser W; Lerch R
    Praxis (Bern 1994); 1995 Oct; 84(42):1181-5. PubMed ID: 7481331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The biophysiology of the cardiovascular system and its therapeutic implications].
    Michel D
    Internist (Berl); 1984 Aug; 25(8):478-84. PubMed ID: 6384113
    [No Abstract]   [Full Text] [Related]  

  • 10. [Classification of the most important coronary drugs according to hemodynamic considerations].
    Hellige G
    Med Klin (Munich); 1987 Jan; 1():14-9. PubMed ID: 3472029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of the prostacyclin analog taprostene on ischemic ST-segment depression in the stress ECG of coronary patients].
    Hopf R; Schöfl E; Frings M; Söhngen W
    Z Kardiol; 1994 Apr; 83(4):258-63. PubMed ID: 8023538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention and the rehabilitative therapy of patients with different forms of coronary pathology. The individual approach and criteria for determining efficacy].
    Karpov RS
    Ter Arkh; 1995; 67(8):34-6. PubMed ID: 7482330
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of the effect of different cardiovasotropic preparations on the contractility of separate sections of the myocardium in acute coronary occlusion].
    Kostin VI; Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1985; 48(6):25-8. PubMed ID: 3936729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term preservation of left ventricular function in medically treated patients with coronary artery disease and persistent exercise-induced ischemia.
    Fragasso G; Xuereb RG; Xuereb M; Rossetti E; Margonato A; Chierchia SL
    Cardiologia; 1999 Mar; 44(3):255-60. PubMed ID: 10327727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
    Stankusheva G; Draganov V; Manolov P
    Vutr Boles; 1987; 26(2):33-8. PubMed ID: 3604194
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of neuroleptanalgesia agents on the collateral coronary circulation and systemic hemodynamics in acute myocardial ischemia].
    Iakushev MP; Sapozhkov AV
    Farmakol Toksikol; 1984; 47(4):59-62. PubMed ID: 6479313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].
    Szucs TD; Schwenkglenks M; Rutishauser W
    Med Klin (Munich); 2000 Jan; 95(1):1-13. PubMed ID: 10668338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reperfusion damages to the heart in acute transitory coronary failure and their prevention with myophedrin].
    Vasilevskaia TA; Litvitskiĭ PF
    Biull Eksp Biol Med; 1985 Jul; 100(7):97-100. PubMed ID: 4016248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic studies on radix puerariae: effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia.
    Fan LL; O'Keefe DD; Powell WW
    Chin Med J (Engl); 1985 Nov; 98(11):821-32. PubMed ID: 3938713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.